Trial Details
ACTIVE_NOT_RECRUITINGBasic Information
| Clinical ID | c2090 |
|---|---|
| Identifier | NCT03992469 |
| Trial Title | Study to Evaluate Safety, Tolerability and Efficacy of Oral E-B-FAHF-2 in Mild-to-Moderate Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: EBFAHF-2|DRUG: Placebo |
Participant Information
| Sponsor | Icahn School of Medicine at Mount Sinai |
|---|---|
| City | Icahn School of Medicine at Mount Sinai |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2023-02-15 |
|---|---|
| Primary Completion Date | 2026-02-02 |
| Completion Date | 2026-02-02 |